Sam Mbulaiteye

Sam Mbulaiteye
EducationMakerere University
University of Cambridge
Scientific career
FieldsCancer epidemiology
WorkplacesNational Cancer Institute

Sam Mbulaiteye (born in 1961) also known as Sam M. Mbulaiteye is a Ugandan physician-scientist and epidemiologist who researches Burkitt lymphoma. He is a senior investigator at the National Cancer Institute. He conducts population studies and uses molecular and proteomic methods to search for risk factors that may be targeted to prevent or identify cancer at early stages.

Early life and education

Sam Mbulaiteye was born in 1961. He completed his advanced secondary education (UACE) at St. Mary's College Kisubi (SMACK) between 1982 and 1985.

Mbulaiteye went to Makerere University where he was trained as a physician in 1990 then joined University of Cambridge, U.K for an advanced training in epidemiology and biostatistics (M.Phil.)in 1994. After there, he was enrolled back at Makerere University for a specialist training in internal medicine (M.Med.).

Career

Current roles and leadership (2025)

  • Senior Investigator. Lead researcher in the Infections and Immunoepidemiology Branch (IIB) of the NCI's Division of Cancer Epidemiology and Genetics (DCEG).
  • Principal Investigator. Heads the EMBLEM Study, a large case-control study investigating the multifactorial causes of Burkitt lymphoma (BL) across Uganda, Tanzania, and Kenya.
  • Editor-in-Chief. Serves as Co-Editor-in-Chief of the journal Infectious Agents and Cancer.
  • Committee Work. Active member of the DCEG Genotyping Review Committee.

Key scientific contributions

  • Burkitt Lymphoma Research: His current work uses genomic methods, including Genome-Wide Association Studies (GWAS), to investigate how repeated malaria infections and the Epstein-Barr virus (EBV) interact to cause BL.
  • HIV/AIDS and Cancer: He was the first to use record-linkage methods to study the association between HIV and cancer in low- and middle-income countries, starting in Uganda in 2005.
  • Global Oncology: He provided early evidence showing declining HIV incidence in Uganda and identified the risk of Kaposi sarcoma-associated herpesvirus (KSHV) transmission via blood transfusions in Africa.

Career timeline

He also holds membership in the Darwin College Society at the University of Cambridge.

Honours

See also